Difference between revisions of "Italiano A, et al. Ann. Oncol. (2013) cited as Ref 608 in DOI: 10.1038/s41392-020-0110-5 (Q9871)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 24, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study (English) | ||
| Property / title: GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:05, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Italiano A, et al. Ann. Oncol. (2013) cited as Ref 608 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Italiano A
0 references
2013
0 references
Ann. Oncol.
0 references
24
0 references
GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study (English)
0 references
